PS Ratio: 25.04

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 25.04 is 52% below its estimated 5-year average of 52.64, near the low end of its estimated 5-year range (12.48–230.36).

As of 2026-10-06T15:42:31.855Z. 24.94% below its estimated 12-month average of 33.36.

LEXX PS Ratio Metrics

P/S vs. estimated history

At 25.04, P/S is below its estimated 6-year median — higher than 11% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Lexaria Bioscience Corp. (LEXX)?

The P/S ratio for LEXX stock is 25.04.

Is Lexaria Bioscience Corp.'s P/S ratio high or low?

The P/S ratio of 25.04 is 52% below its estimated 5-year average of 52.64, near the low end of its estimated 5-year range (12.48–230.36).

What is the estimated TTM average P/S ratio for Lexaria Bioscience Corp. (LEXX)?

The estimated TTM average P/S ratio for LEXX stock is 33.36.

What is the estimated 3Y average P/S ratio for Lexaria Bioscience Corp. (LEXX)?

The estimated 3Y average P/S ratio for LEXX stock is 57.43.

What is the estimated 5Y average P/S ratio for Lexaria Bioscience Corp. (LEXX)?

The estimated 5Y average P/S ratio for LEXX stock is 52.64.

Showing the most recent 260 of 1,439 data points. The chart above shows the full history.

Related Metrics